‘Low-Intensity’ Blood Stem Cell Transplants May Improve Lung Function in Sickle Cell

Low-intensity blood SCTs, which use milder conditioning agents than standard SCTs, may approve lung function in ...

SEPTEMBER 10, 2024

Mainstay IBD Treatment Reduces Lower-GI aGVHD After Allo-HSCT

Vedolizumab, a drug used frequently for inflammatory bowel disease, improves outcomes in patients undergoing ...

APRIL 12, 2023

Many Differences in Latest HIV Patient to Achieve HIV Remission With HSCT

A 66-year-old patient living with HIV and acute myeloid leukemia achieved complete remission from both his HIV and ...

JULY 27, 2022

Clonal Hematopoiesis in Donors May Improve Bone Marrow Transplant Outcome

Clinicians tend to stay away from older donors with clonal hematopoiesis because of concerns about passing ...

NOVEMBER 23, 2021

Propylene Glycol–Free Melphalan Passes Safety Test

Toxicity issues related to propylene glycol–free melphalan in patients with multiple myeloma undergoing ...

JUNE 8, 2021

FDA Approves Prevymis to Prevent CMV Among Stem Cell Transplant Patients

The FDA approved Merck's Prevymis, Merck for prophylaxis of cytomegalovirus infection and disease in adult ...

NOVEMBER 9, 2017

FDA Expands Indication for Revlimid for Certain MM Patients

Celgene's Revlimid has a new indication: for MM patients following autologous hematopoietic stem cell ...

FEBRUARY 23, 2017